BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36747196)

  • 1. Multiparameter diagnostic model based on
    Li C; Luan X; Bi X; Chen S; Pan Y; Zhang J; Han Y; Xu X; Wang G; Xu B
    BMC Cancer; 2023 Feb; 23(1):119. PubMed ID: 36747196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparameter diagnostic model based on
    Wang G; Du L; Lu X; Liu J; Zhang M; Pan Y; Meng X; Xu X; Guan Z; Yang J
    BMC Cancer; 2022 Aug; 22(1):895. PubMed ID: 35974323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparameter diagnostic model based on
    Wang G; Du L; Lu X; Chen S; Bi X; Zhang M; Luan X; Xu X; Zhang Z; Xu B; Yang J
    Quant Imaging Med Surg; 2023 Sep; 13(9):5653-5663. PubMed ID: 37711769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Added Value of
    Chen S; Wang G; Wu L; Chen D; Fang K; Liu W; Xu B; Zhai YQ; Li M
    BMC Gastroenterol; 2024 Jan; 24(1):37. PubMed ID: 38233765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Combination of
    Wang G; Liu X; Chen J; Zhang F; Xu X; Wang Y; Wang R; Yao S; Zhu J; Guan Z
    Contrast Media Mol Imaging; 2022; 2022():9614678. PubMed ID: 35494209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical value of texture analysis of dual-time-point
    Nakajo M; Jinguji M; Aoki M; Tani A; Sato M; Yoshiura T
    Eur Radiol; 2020 Mar; 30(3):1759-1769. PubMed ID: 31728684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of 2-deoxy-2-fluorine-18-fluoro-D-glucose positron emission tomography/computed tomography parameters for MYCN amplification in high-risk neuroblastoma.
    Li S; Liu J; Wang G; Feng L; Yang X; Kan Y; Wang W; Yang J
    Eur J Radiol; 2024 Jan; 170():111243. PubMed ID: 38043380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of Metabolic Parameters Derived From
    Liu H; Ye Z; Yang T; Xie H; Duan T; Li M; Wu M; Song B
    Front Immunol; 2021; 12():724464. PubMed ID: 34512653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of
    Rufini V; Collarino A; Calcagni ML; Meduri GM; Fuoco V; Pasciuto T; Testa AC; Ferrandina G; Gambacorta MA; Campitelli M; Gui B; Zannoni G; Manfredi R; Scambia G; Giordano A
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1228-1238. PubMed ID: 31414206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
    Ciftci E; Turgut B; Cakmakcilar A; Erturk SA
    Nucl Med Commun; 2017 Sep; 38(9):788-794. PubMed ID: 28692494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic values of 2-[
    Han S; Kim YI; Oh JS; Seo SY; Park MJ; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
    Eur Radiol; 2022 Feb; 32(2):1173-1183. PubMed ID: 34448035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of 18F-FDG PET/CT in staging of gallbladder carcinomas.
    Arslan E; Aksoy T; Dursun N; Gürsu RU; Sevinç MM; Çermik TF
    Turk J Gastroenterol; 2020 Feb; 31(2):105-112. PubMed ID: 32141818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
    Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH
    J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma.
    Nishiyama Y; Yamamoto Y; Fukunaga K; Kimura N; Miki A; Sasakawa Y; Wakabayashi H; Satoh K; Ohkawa M
    J Nucl Med; 2006 Apr; 47(4):633-8. PubMed ID: 16595497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparameter Analysis Using
    Wang G; Dang H; Yu P; Liu H; Wu Y; Yao S; Tian J; Ye H; Xu B
    Contrast Media Mol Imaging; 2021; 2021():6658644. PubMed ID: 33880111
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
    Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Nakajo M; Jinguji M; Shinaji T; Tani A; Nakabeppu Y; Nakajo M; Nakajo A; Natsugoe S; Yoshiura T
    Br J Radiol; 2019 Feb; 92(1094):20180620. PubMed ID: 30273012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Value of Volume-Based Fluorine-18-Fluorodeoxyglucose PET/CT Parameters for Characterizing Thyroid Incidentaloma.
    Shi H; Yuan Z; Yuan Z; Yang C; Zhang J; Shou Y; Zhang W; Ping Z; Gao X; Liu S
    Korean J Radiol; 2018; 19(2):342-351. PubMed ID: 29520193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.